Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...

Analysts say Eli Lilly may have a future blockbuster drug on its hands: An experimental pill designed to lower ... so lifestyle changes such as diet or exercise have no effect, Ruth Gimeno ...

Eli Lilly’s retatrutide is called “triple G ... Liraglutide, a daily GLP-1 drug, brought weight loss of up to 5.8% after 26 weeks. A pill form of semaglutide brought similar weight loss ...

Eli Lilly shares dropped after the drugmaker cut its 2024 revenue guidance, citing lower-than-expected demand for its obesity ...

Eli Lilly's stock price finished ... About a year from now, Lilly could cement its lead in the weight loss medication market. According to Ricks, the company expects approval of an oral weight-loss ...

Traders are comparing U.S. weight-loss drug innovator Eli Lilly to artificial ... Baron ranks Structure second behind Lilly in the race to get a weight-loss pill to market. Structure is also ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound ... increased physical activity and a reduced-calorie diet. Obstructive sleep apnea occurs when a person’s ...